Chronic immune activation and inflammation as the cause of malignancy
暂无分享,去创建一个
[1] N. Altorki,et al. Inhibition of Cyclooxygenase‐2 , 2001, Annals of the New York Academy of Sciences.
[2] Z-G Xu,et al. The latency pattern of Epstein–Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas , 2001, British Journal of Cancer.
[3] L. Hansson,et al. Aspirin and risk for gastric cancer: a population-based case–control study in Sweden , 2001, British Journal of Cancer.
[4] A. Kim,et al. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. , 2001, Biochemical and biophysical research communications.
[5] T. Naoe,et al. Epstein–Barr virus‐encoded poly(A)− RNA supports Burkitt's lymphoma growth through interleukin‐10 induction , 2000, The EMBO journal.
[6] M. Pawlita,et al. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7 , 2000, The Lancet.
[7] E. Hahn,et al. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. , 2000, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[8] J. Jansson,et al. Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6(-/-)) mice. , 2000, Journal of hepatology.
[9] C. E. Houghton,et al. Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres. , 2000, Carcinogenesis.
[10] M. Luster,et al. Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] P. Ricchi,et al. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells , 2000, Oncogene.
[12] C. Clavel,et al. Human Papillomavirus Detection by the Hybrid Capture II Assay: A Reliable Test to Select Women With Normal Cervical Smears at Risk for Developing Cervical Lesions , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[13] K R Abrams,et al. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems , 2000, Thorax.
[14] T. Yoshizaki,et al. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma , 2000, Cancer.
[15] A. Beyerle,et al. UVB-induced Epidermal Growth Factor Receptor Phosphorylation is Critical for Downstream Signaling and Keratinocyte Survival¶ , 2000, Photochemistry and photobiology.
[16] L. Aarden,et al. Epstein‐Barr virus‐dependent lymphoproliferative disease: critical role of IL‐6 , 2000, European journal of immunology.
[17] R. Lancashire,et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.
[18] J. Chen,et al. Expression of the Epstein‐Barr virus BHRF1 gene, a homologue of Bcl‐2, in nasopharyngeal carcinoma tissue , 2000, Journal of medical virology.
[19] K. O'Byrne,et al. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] S. Pettit,et al. Immune selection in neoplasia: towards a microevolutionary model of cancer development , 2000, British Journal of Cancer.
[21] Jaap M Middeldorp,et al. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. , 2000, Cancer research.
[22] M J Dunn,et al. Cyclooxygenase-2 Expression Inhibits Trophic Withdrawal Apoptosis in Nerve Growth Factor-differentiated PC12 Cells* , 2000, The Journal of Biological Chemistry.
[23] M. Hung,et al. HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.
[24] M. Yu,et al. Non-steroidal anti-inflammatory drugs and bladder cancer prevention , 2000, British Journal of Cancer.
[25] A. Dalgleish,et al. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection , 2000, British Journal of Cancer.
[26] K J O'Byrne,et al. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. , 2000, European journal of cancer.
[27] Vaganova Ig. Apoptosis and proliferation of epithelial cells in papillomaviral and chlamydial cervicitis , 2000 .
[28] A. Raza,et al. Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: common themes and emerging patterns. , 2000, Leukemia research.
[29] I. Vaganova. [Apoptosis and proliferation of epithelial cells in papillomaviral and chlamydial cervicitis]. , 2000, Voprosy onkologii.
[30] M. You,et al. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. , 2000, Experimental lung research.
[31] E. Kremmer,et al. Detection of Epstein-Barr virus in invasive breast cancers. , 1999, Journal of the National Cancer Institute.
[32] Y. Sasaki,et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[33] S. Meri,et al. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. , 1999, Immunology today.
[34] T. Mitsuya,et al. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1. , 1999, Virus research.
[35] T. Tsuruo,et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522 , 1999, British Journal of Cancer.
[36] G. Hannon,et al. A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.
[37] Carlos Cordon-Cardo,et al. At the Crossroads of Inflammation and Tumorigenesis , 1999, The Journal of experimental medicine.
[38] R. Pounder,et al. Helicobacter pylori: from the benign to the malignant. , 1999, The American journal of gastroenterology.
[39] H. Sato,et al. Activation of matrix metalloproteinase‐2 in human breast cancer cells overexpressing cyclooxygenase‐1 or ‐2 , 1999, FEBS letters.
[40] A. Burny,et al. HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[41] J. Shah,et al. Inhibition of Cyclooxygenase‐2 Expression: An Approach to Preventing Head and Neck Cancer , 1999, Annals of the New York Academy of Sciences.
[42] M. Imamura,et al. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors , 1999, International journal of pancreatology : official journal of the International Association of Pancreatology.
[43] Yu-Chung Wu,et al. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan , 1999, American Journal of Gastroenterology.
[44] D. Carbone,et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] S. You,et al. Reproductive and infectious risk factors for invasive cervical cancer in Taiwan. , 1999, Anticancer research.
[46] F. Saint,et al. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group. , 1999, Urology.
[47] A. Moscicki,et al. Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection , 1999, Clinical Diagnostic Laboratory Immunology.
[48] C. Meijer,et al. Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. , 1999, The Journal of general virology.
[49] F. Sinicrope,et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.
[50] Tianxin Yang,et al. Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro. , 1999, American journal of physiology. Renal physiology.
[51] B. Baban,et al. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[52] K. Okita,et al. Metaplastic polyp of the colon develops in response to inflammation , 1999, Journal of gastroenterology and hepatology.
[53] L. Young,et al. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. , 1999, The Journal of biological chemistry.
[54] G. Kirk,et al. CROHN'S DISEASE AND COLORECTAL MALIGNANCY , 1999, International journal of clinical practice.
[55] G. Lichtenstein,et al. Cancer risk in patients with inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.
[56] A. Dalgleish,et al. The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. , 1999, QJM : monthly journal of the Association of Physicians.
[57] J C Imperial,et al. Natural history of chronic hepatitis B and C , 1999, Journal of gastroenterology and hepatology.
[58] D. Hanahan,et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.
[59] J. Carlstedt-Duke,et al. Involvement of Tyrosine Kinases on Cyclooxygenase Expression and Prostaglandin E2Production in Human Gingival Fibroblasts Stimulated with Interleukin-1β and Epidermal Growth Factor , 1999 .
[60] E. Wynder,et al. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. , 1999, Cancer research.
[61] D. Kerr,et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.
[62] C. Tsai,et al. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. , 1999, Cancer research.
[63] J. McCann. Esophageal cancers: changing character, increasing incidence. , 1999, Journal of the National Cancer Institute.
[64] R. Alexander,et al. Polymerase chain reaction amplification of bacterial 16s rRNA genes in prostate biopsies from men without chronic prostatitis. , 1999, Urology.
[65] D. S. Coffey,et al. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. , 1999, Urology.
[66] M. Sherman,et al. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[67] J. Dillner,et al. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. , 1999, The Journal of general virology.
[68] H. Shiozaki,et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma , 1999, American Journal of Gastroenterology.
[69] P. Baeuerle,et al. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[70] S. Fleming. Renal cancer genetics: von Hippel Lindau and other syndromes. , 1999, The International journal of developmental biology.
[71] M. Spitz,et al. Genetic susceptibility to tobacco carcinogenesis. , 1999, Cancer investigation.
[72] S. Mayne,et al. Previous lung disease and risk of lung cancer among men and women nonsmokers. , 1999, American journal of epidemiology.
[73] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[74] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.
[75] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[76] M. Taketo. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). , 1998, Journal of the National Cancer Institute.
[77] M. Hori,et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.
[78] D. Hanahan,et al. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. , 1998, Cancer research.
[79] A. Lau,et al. Tumor Suppressor p53 as a Component of the Tumor Necrosis Factor-induced, Protein Kinase PKR-mediated Apoptotic Pathway in Human Promonocytic U937 Cells* , 1998, The Journal of Biological Chemistry.
[80] C. Boshoff,et al. Kaposi's sarcoma herpesvirus as a new paradigm for virus‐induced oncogenesis , 1998, Current opinion in oncology.
[81] K. Schrör,et al. Augmented myocardial ischaemia by nicotine – Mechanisms and their possible significance , 1998, British journal of pharmacology.
[82] M. Piccinni,et al. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions , 1998, Nature Medicine.
[83] P. Lipsky,et al. Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[84] D. S. Coffey. Self-organization, complexity and chaos: The new biology for medicine , 1998, Nature Medicine.
[85] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[86] H. Vapaatalo,et al. Nicotine stereoisomers and cotinine stimulate prostaglandin E2 but inhibit thromboxane B2 and leukotriene E4 synthesis in whole blood. , 1998, European journal of pharmacology.
[87] Y. Takei,et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. , 1998, The American journal of physiology.
[88] S. Loening,et al. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. , 1998, The Journal of urology.
[89] C. de Bragança Pereira,et al. Genetic Damage in Exfoliated Cells of the Uterine Cervix , 1998, Acta Cytologica.
[90] A. Barbul,et al. Lymphocyte function in wound healing and following injury , 1998, The British journal of surgery.
[91] Li Zhu,et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. , 1998, Cancer research.
[92] P. Delvenne,et al. Correlation of T‐helper secretory differentiation and types of antigen‐presenting cells in squamous intraepithelial lesions of the uterine cervix , 1998, The Journal of pathology.
[93] A. Makheja,et al. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. , 1998, Anticancer research.
[94] P. Galle,et al. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. , 1998, Molecular medicine today.
[95] Dalgleish,et al. Abnormal intracellular IL‐2 and interferon‐gamma (IFN‐γ) production as HIV‐1‐associated markers of immune dysfunction , 1998, Clinical and experimental immunology.
[96] P. Delvenne,et al. Inverse modulation of IL‐10 and IL‐12 in the blood of women with preneoplastic lesions of the uterine cervix , 1998, Clinical and experimental immunology.
[97] M. Hori,et al. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development. , 1998, Journal of clinical gastroenterology.
[98] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[99] A. Orucevic,et al. Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice , 1997, International journal of cancer.
[100] S. Goerdt,et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. , 1997, Immunobiology.
[101] Andrew J. Dannenberg,et al. Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[102] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[103] S. Loric,et al. Acute bacterial prostatitis induces hematogenous dissemination of prostate epithelial cells. , 1997, Clinical chemistry.
[104] J. Berzofsky,et al. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[105] J. Myklebust,et al. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21‐ras (12VAL) peptide vaccination of a patient, recognize 12VAL‐dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation , 1997, International journal of cancer.
[106] S. Faux,et al. Possible role of lipid peroxidation in the induction of NF-kappa B and AP-1 in RFL-6 cells by crocidolite asbestos: evidence following protection by vitamin E. , 1997, Environmental health perspectives.
[107] D. Umetsu,et al. T helper 2-dominant antilymphoma immune response is associated with fatal outcome. , 1997, Blood.
[108] B. Mossman,et al. Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells. , 1997, The American journal of pathology.
[109] S. Steinberg,et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas , 1997, Nature Medicine.
[110] H. Pass,et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas , 1997, Nature Medicine.
[111] J. Wigginton,et al. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. , 1997, The American journal of pathology.
[112] A. Castonguay,et al. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. , 1997, Carcinogenesis.
[113] T. Akaike,et al. Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. , 1997, Journal of biochemistry.
[114] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[115] R. Scorza,et al. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.
[116] S. Yamamoto,et al. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. , 1997, Japanese journal of pharmacology.
[117] P. Uotila. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer , 1996, Cancer Immunology, Immunotherapy.
[118] L. Guillou,et al. Germ cell tumors of the testis overexpress wild-type p53. , 1996, The American journal of pathology.
[119] H. Fusamoto,et al. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[120] T. Osato,et al. Epstein-Barr virus and gastric carcinoma. , 1996, Seminars in cancer biology.
[121] D. Fitzpatrick,et al. MOLECULAR PATHOBIOLOGY AND IMMUNOLOGY OF MALIGNANT MESOTHELIOMA , 1996, The Journal of pathology.
[122] J. Ka,et al. Aspirin and the risk of colorectal cancer in women. , 1996 .
[123] J. Folkman. Clinical Applications of Research on Angiogenesis , 1995 .
[124] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[125] E. Funkhouser,et al. Aspirin and reduced risk of esophageal carcinoma , 1995, Cancer.
[126] W C Willett,et al. Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.
[127] R. Weiss. Viruses and Cancer , 1995, British Journal of Cancer.
[128] T. Maniatis,et al. NF-κB: A lesson in family values , 1995, Cell.
[129] P. O'connor,et al. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[130] J. Folkman. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.
[131] J. Richards,et al. Ovarian cell differentiation: a cascade of multiple hormones, cellular signals, and regulated genes. , 1995, Recent progress in hormone research.
[132] M. Clerici,et al. The Th1-Th2 hypothesis of HIV infection: new insights. , 1994, Immunology today.
[133] K. Dameron,et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.
[134] E. Rimm,et al. Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.
[135] S. Lightman,et al. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. , 1994, Immunology today.
[136] A. Paganini-Hill. Aspirin and the prevention of colorectal cancer: a review of the evidence. , 1994, Seminars in surgical oncology.
[137] R. Everson,et al. Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.
[138] P. Doherty,et al. Evasion of host immune responses by tumours and viruses. , 1994, Ciba Foundation symposium.
[139] H. Yamanaka,et al. [Study of risk factors for prostatic cancer]. , 1993, Hinyokika kiyo. Acta urologica Japonica.
[140] P. Stern,et al. Natural history of HLA expression during tumour development. , 1993, Immunology today.
[141] White Cd,et al. Inflammatory cell infiltrate in the cervix as a predictor of residual cervical intraepithelial neoplasia after conization. , 1992 .
[142] Dalgleish Ag. The pathogenesis of AIDS: classical and alternative views. , 1992 .
[143] A. Ullrich,et al. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors , 1992, Molecular and cellular biology.
[144] J. Habeshaw,et al. Does the HIV envelope induce a chronic graft-versus-host-like disease? , 1992, Immunology today.
[145] A. Dalgleish. The Pathogenesis of AIDS: Classical and Alternative Views , 1992, Journal of the Royal College of Physicians of London.
[146] Cancer Prevention Study II. The American Cancer Society Prospective Study. , 1992, Statistical bulletin.
[147] C. D. White,et al. Inflammatory cell infiltrate in the cervix as a predictor of residual cervical intraepithelial neoplasia after conization. , 1992, The Journal of reproductive medicine.
[148] M. Thun,et al. Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.
[149] Melief Cj,et al. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. , 1991 .
[150] T. Wallington,et al. Immunomodulation by ultraviolet light: clinical studies and biological effects. , 1991, Immunology today.
[151] W. Kast,et al. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms. , 1991, Seminars in cancer biology.
[152] E. E. Gresch. Genetic Alterations During Colorectal-Tumor Development , 1989 .
[153] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.
[154] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[155] N. Hildreth,et al. The influence of potential biases on the risk of breast tumors among women who received radiotherapy for acute postpartum mastitis. , 1986, Journal of chronic diseases.
[156] M. Bowman. Introduction and Historical Perspective , 1978 .
[157] O. Plescia,et al. Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis. , 1977, Prostaglandins.
[158] T. Mack,et al. CHRONIC MASTITIS AND CARCINOMA OF BREAST , 1977, The Lancet.